R
Robert M. Grant
Researcher at University of California, San Francisco
Publications - 466
Citations - 29445
Robert M. Grant is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Pre-exposure prophylaxis & Men who have sex with men. The author has an hindex of 76, co-authored 437 publications receiving 26835 citations. Previous affiliations of Robert M. Grant include University of Colorado Denver & Makerere University.
Papers
More filters
Journal ArticleDOI
Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients.
Edward L. Murphy,Robert M. Grant,Jerry Kropp,Adriano Oliveira,Tzong-Hae Lee,Michael P. Busch +5 more
Journal ArticleDOI
Resistance Testing in Drug-Naive HIV-Infected Patients: Is it Time?
Frederick Hecht,Robert M. Grant +1 more
TL;DR: Hecht et al. as discussed by the authors presented a cost-effectiveness analysis that supports the use of genotypic drug-resistance testing for all drug-naive patients in most settings.
Journal ArticleDOI
Discovery of genetic variants of the kinases that activate tenofovir among individuals in the United States, Thailand, and South Africa: HPTN067.
Dominique B. Figueroa,Joseph Tillotson,Maoji Li,Estelle Piwowar-Manning,Craig W. Hendrix,Timothy H. Holtz,Kevin Bokoch,Linda-Gail Bekker,Frits van Griensven,Sharon Mannheimer,James P. Hughes,Robert M. Grant,Namandjé N. Bumpus +12 more
TL;DR: In this paper, genomic DNA isolated from dried blood spots collected from 505 participants from Bangkok, Thailand; Cape Town, South Africa; and New York City, USA were examined for variants in AK2, CKM, PKM, and PKLR using next-generation sequencing.
Journal ArticleDOI
Brief Report: Cocaine Use and Pre-exposure Prophylaxis: Adherence, Care Engagement, and Kidney Function
Jose Carlo Hojilla,Jose Carlo Hojilla,Derek D. Satre,Derek D. Satre,David V. Glidden,Vanessa McMahan,Monica Gandhi,Patricia Defechereux,Juan V. Guanira,Megha Mehrotra,Robert M. Grant,Adam W. Carrico +11 more
TL;DR: Concomitant use of cocaine and HIV pre-exposure prophylaxis (PrEP) raises important clinical questions around adherence, retention in care, and renal toxicity and comprehensive approaches are needed to reduce cocaine use and enhance engagement along the PrEP care continuum.